Litcius/Paper detail

Multiple Sclerosis Disease-Modifying Therapy and the COVID-19 Pandemic: Implications on the Risk of Infection and Future Vaccination

Crystal Zheng, Indrani Kar, Claire Kaori Chen, Crystal Sau, Sophia Woodson, Alessandro Serra, Hesham Abboud

2020CNS Drugs98 citationsDOIOpen Access PDF

Topics & Concepts

MedicineNatalizumabMultiple sclerosisPandemicFingolimodImmune systemDiseaseImmunologyCoronavirusCytokine stormVaccinationIntensive care medicineCoronavirus disease 2019 (COVID-19)Infectious disease (medical specialty)Internal medicineMultiple Sclerosis Research StudiesSARS-CoV-2 and COVID-19 ResearchPolyomavirus and related diseases
Multiple Sclerosis Disease-Modifying Therapy and the COVID-19 Pandemic: Implications on the Risk of Infection and Future Vaccination | Litcius